Dose-dependent effects of Alveofact with and without steroids on neutrophil extracellular traps in neonatal respiratory distress syndrome
gov/study/NCT06367881?term=NCT06367881&rank=1 IMPACT: High-dose Alveofact + budesonide lowers NETs, PAD4, and oxidative stress. Plasma NETs strongly correlate with normalized tracheal aspirates NETs. First trial to test surfactant-steroid effects on neutrophil pathways in RDS. Therapy reduces neutrophil-mediated inflammation in preterm neonates. Plasma NETs may serve as a minimally invasive biomarker for RDS monitoring.
Authors
- Amira M Rashad
- Hisham A. Awad
- Ghada I. Gad
- Nashwa El-Khazragy
- Dina Rabie
Institutions
- Ain Shams University (EG)
Publication Details
- Journal
- Pediatric Research
- Published
- 2026-03-23
- DOI
- https://doi.org/10.1038/s41390-026-04824-9
- Primary Topic
- Neonatal Respiratory Health Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00